182 related articles for article (PubMed ID: 31434227)
21. Maltol Mitigates Thioacetamide-induced Liver Fibrosis through TGF-β1-mediated Activation of PI3K/Akt Signaling Pathway.
Mi XJ; Hou JG; Jiang S; Liu Z; Tang S; Liu XX; Wang YP; Chen C; Wang Z; Li W
J Agric Food Chem; 2019 Feb; 67(5):1392-1401. PubMed ID: 30644744
[TBL] [Abstract][Full Text] [Related]
22. Immunomodulatory liposomes targeting liver macrophages arrest progression of nonalcoholic steatohepatitis.
Maradana MR; Yekollu SK; Zeng B; Ellis J; Clouston A; Miller G; Talekar M; Bhuyan ZA; Mahadevaiah S; Powell EE; Irvine KM; Thomas R; O'Sullivan BJ
Metabolism; 2018 Jan; 78():80-94. PubMed ID: 28941597
[TBL] [Abstract][Full Text] [Related]
23. Asialoglycoprotein receptor-targeted liposomes loaded with a norcantharimide derivative for hepatocyte-selective targeting.
Liu X; Han M; Xu J; Geng S; Zhang Y; Ye X; Gou J; Yin T; He H; Tang X
Int J Pharm; 2017 Mar; 520(1-2):98-110. PubMed ID: 28167263
[TBL] [Abstract][Full Text] [Related]
24. Histological evaluation of nintedanib in non-alcoholic steatohepatitis mice.
Susutlertpanya W; Wakuda H; Otani N; Kuramoto T; Li L; Kuranari M; Sekiguchi A; Kudo H; Uchida T; Imai H; Uemura N
Life Sci; 2019 Jul; 228():251-257. PubMed ID: 31078545
[TBL] [Abstract][Full Text] [Related]
25. Scavenging of hydroxyl radicals in aqueous solution by astaxanthin encapsulated in liposomes.
Hama S; Uenishi S; Yamada A; Ohgita T; Tsuchiya H; Yamashita E; Kogure K
Biol Pharm Bull; 2012; 35(12):2238-42. PubMed ID: 23207776
[TBL] [Abstract][Full Text] [Related]
26. Modulation of liver fibrosis and pathophysiological changes in mice infected with Mesocestoides corti (M. vogae) after administration of glucan and liposomized glucan in combination with vitamin C.
Ditteová G; Velebný S; Hrckova G
J Helminthol; 2003 Sep; 77(3):219-26. PubMed ID: 12895280
[TBL] [Abstract][Full Text] [Related]
27. The protective effects of astaxanthin against cisplatin-induced retinal toxicity.
Fındık H; Tumkaya L; Yılmaz A; Gökhan Aslan M; Okutucu M; Akyildiz K; Mercantepe T
Cutan Ocul Toxicol; 2019 Mar; 38(1):59-65. PubMed ID: 30185066
[TBL] [Abstract][Full Text] [Related]
28. Biotechnological Applications for the Sustainable Use of Marine By-products: In Vitro Antioxidant and Pro-apoptotic Effects of Astaxanthin Extracted with Supercritical CO
Messina CM; Manuguerra S; Renda G; Santulli A
Mar Biotechnol (NY); 2019 Aug; 21(4):565-576. PubMed ID: 31079239
[TBL] [Abstract][Full Text] [Related]
29. Astaxanthin pretreatment attenuates acetaminophen-induced liver injury in mice.
Zhang J; Zhang S; Bi J; Gu J; Deng Y; Liu C
Int Immunopharmacol; 2017 Apr; 45():26-33. PubMed ID: 28152447
[TBL] [Abstract][Full Text] [Related]
30. Improved Hepatoprotective Effect of Liposome-Encapsulated Astaxanthin in Lipopolysaccharide-Induced Acute Hepatotoxicity.
Chiu CH; Chang CC; Lin ST; Chyau CC; Peng RY
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27428953
[TBL] [Abstract][Full Text] [Related]
31. Protective effects of topical application of a poorly soluble antioxidant astaxanthin liposomal formulation on ultraviolet-induced skin damage.
Hama S; Takahashi K; Inai Y; Shiota K; Sakamoto R; Yamada A; Tsuchiya H; Kanamura K; Yamashita E; Kogure K
J Pharm Sci; 2012 Aug; 101(8):2909-16. PubMed ID: 22628205
[TBL] [Abstract][Full Text] [Related]
32. Calycosin attenuates triglyceride accumulation and hepatic fibrosis in murine model of non-alcoholic steatohepatitis via activating farnesoid X receptor.
Duan X; Meng Q; Wang C; Liu Z; Liu Q; Sun H; Sun P; Yang X; Huo X; Peng J; Liu K
Phytomedicine; 2017 Feb; 25():83-92. PubMed ID: 28190475
[TBL] [Abstract][Full Text] [Related]
33. [Establishment of a complex alcoholic liver fibrosis mouse model and investigation of OPN and TGF-beta1 hepatic expression].
Kong LB; Ren WG; Mi HM; Zhao SX; Zhang YG; Nan YM
Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):207-12. PubMed ID: 23967743
[TBL] [Abstract][Full Text] [Related]
34. [Comparison of effect of formulas clearing away heat and promoting blood circulation on prevention and treatment of liver fibrosis in CCl4 mice].
Zhao Z; Yu H; Peng Y; Ren H; Tao Y; Wang Z; Zhu B; Liu P; Liu C
Zhongguo Zhong Yao Za Zhi; 2012 Jun; 37(12):1804-8. PubMed ID: 22997828
[TBL] [Abstract][Full Text] [Related]
35. Current data on ATP-containing liposomes and potential prospects to enhance cellular energy status for hepatic applications.
Korb V; Tep K; Escriou V; Richard C; Scherman D; Cynober L; Chaumeil J; Dumortier G
Crit Rev Ther Drug Carrier Syst; 2008; 25(4):305-45. PubMed ID: 18540841
[TBL] [Abstract][Full Text] [Related]
36. Antifibrotic effect of diethylcarbamazine combined with hesperidin against ethanol induced liver fibrosis in rats.
El-Sisi AEE; Sokar SS; Shebl AM; Mohamed DZ
Biomed Pharmacother; 2017 May; 89():1196-1206. PubMed ID: 28320086
[TBL] [Abstract][Full Text] [Related]
37. Comparative Analysis of EPA/DHA-PL Forage and Liposomes in Orotic Acid-Induced Nonalcoholic Fatty Liver Rats and Their Related Mechanisms.
Chang M; Zhang T; Han X; Tang Q; Yanagita T; Xu J; Xue C; Wang Y
J Agric Food Chem; 2018 Feb; 66(6):1408-1418. PubMed ID: 29345914
[TBL] [Abstract][Full Text] [Related]
38. Anti-fibrotic effects of neferine on carbon tetrachloride-induced hepatic fibrosis in mice.
Chen MS; Zhang JH; Wang JL; Gao L; Chen XX; Xiao JH
Am J Chin Med; 2015; 43(2):231-40. PubMed ID: 25800905
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of Losartan-Loaded Hyaluronic Acid (HA) Micelles for the Reduction of Advanced Hepatic Fibrosis in C3H/HeN Mice Model.
Thomas RG; Moon MJ; Kim JH; Lee JH; Jeong YY
PLoS One; 2015; 10(12):e0145512. PubMed ID: 26714035
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic effect of liposomal-N-acetylcysteine against acetaminophen-induced hepatotoxicity.
Alipour M; Buonocore C; Omri A; Szabo M; Pucaj K; Suntres ZE
J Drug Target; 2013 May; 21(5):466-73. PubMed ID: 23600745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
